ANDA 208181, held by Amneal Pharms Co. Tiagabine Hydrochloride.
As of Nov 16, 2026, ANDA 208181 (Tiagabine Hydrochloride), held by Amneal Pharms Co, was first approved by FDA on Dec 8, 2017, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 8, 2017 | Original application | Approved | None posted |
| Tiagabine Hydrochloride2MG · tablet;oral | Tiagabine Hydrochloride | Discontinued |
| Tiagabine Hydrochloride4MG · tablet;oral | Tiagabine Hydrochloride | Discontinued |
| Tiagabine Hydrochloride12MG · tablet;oral | Tiagabine Hydrochloride | Discontinued |
| Tiagabine Hydrochloride16MG · tablet;oral | Tiagabine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters